TY - JOUR
T1 - Dopamine D(1A) receptor regulation of phospholipase C isoform
AU - Yu, Pei Ying
AU - Eisner, Gilbert M.
AU - Yamaguchi, Ikuyo
AU - Mouradian, Maral M.
AU - Felder, Robin A.
AU - Jose, Pedro A.
PY - 1996
Y1 - 1996
N2 - In LTK- cells stably transfected with rat D(1A) receptor cDNA, fenoldopam, a D1 agonist, increased phosphatidylinositol 4,5-bisphosphate hydrolysis in a time-dependent manner. In the cytosol, phospholipase C (PLC) activity increased (50 ± 7%) in 30 s, returned to basal level at 4 h, and decreased below basal values by 24 h; in the membrane, PLC activity also increased (36 ± 13%) in 30 s, returned to basal level at 10 min, and decreased below basal value at 4 and 24 h. Fenoldopam also increased PLC-γ protein in a time-dependent manner. The latter was blocked by the D1 antagonist SKF83742 and by a D(1A) antisense oligodeoxynucleotide, indicating involvement of the D(1A) receptor. The fenoldopam-induced increase in PLC-γ and activity was mediated by protein kinase A (PKA) since it was blocked by the PKA antagonist R(p)-8-CTP-adenosine cyclic 3':5'- monophosphorothioate (R(p)-8-CTP-cAMP-S) and mimicked by direct stimulation of adenylyl cyclase with forskolin or by a PKA agonist, S(p)-cAMP-S. Protein kinase C (PKC) was also involved, since the fenoldopam-induced increase in PLC-γ protein was blocked by two different PKC inhibitors, calphostin C and chelerythrine; calphostin C also blocked the fenoldopam-induced increase in PLC activity. In addition, forskolin and a PKA agonist, S(p)-8-CTP-cAMP-S, increased PKC activity, and direct stimulation of PKC with phorbol 12- myristate 13-acetate increased PLC-γ protein and activity, effects that were blocked by calphostin C. We suggest that the D(1A)-mediated stimulation of PLC occurs as a result of PKA activation. PKA then stimulates PLC-γ in cytosol and membrane via activation of PKC.
AB - In LTK- cells stably transfected with rat D(1A) receptor cDNA, fenoldopam, a D1 agonist, increased phosphatidylinositol 4,5-bisphosphate hydrolysis in a time-dependent manner. In the cytosol, phospholipase C (PLC) activity increased (50 ± 7%) in 30 s, returned to basal level at 4 h, and decreased below basal values by 24 h; in the membrane, PLC activity also increased (36 ± 13%) in 30 s, returned to basal level at 10 min, and decreased below basal value at 4 and 24 h. Fenoldopam also increased PLC-γ protein in a time-dependent manner. The latter was blocked by the D1 antagonist SKF83742 and by a D(1A) antisense oligodeoxynucleotide, indicating involvement of the D(1A) receptor. The fenoldopam-induced increase in PLC-γ and activity was mediated by protein kinase A (PKA) since it was blocked by the PKA antagonist R(p)-8-CTP-adenosine cyclic 3':5'- monophosphorothioate (R(p)-8-CTP-cAMP-S) and mimicked by direct stimulation of adenylyl cyclase with forskolin or by a PKA agonist, S(p)-cAMP-S. Protein kinase C (PKC) was also involved, since the fenoldopam-induced increase in PLC-γ protein was blocked by two different PKC inhibitors, calphostin C and chelerythrine; calphostin C also blocked the fenoldopam-induced increase in PLC activity. In addition, forskolin and a PKA agonist, S(p)-8-CTP-cAMP-S, increased PKC activity, and direct stimulation of PKC with phorbol 12- myristate 13-acetate increased PLC-γ protein and activity, effects that were blocked by calphostin C. We suggest that the D(1A)-mediated stimulation of PLC occurs as a result of PKA activation. PKA then stimulates PLC-γ in cytosol and membrane via activation of PKC.
UR - http://www.scopus.com/inward/record.url?scp=0029666478&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029666478&partnerID=8YFLogxK
U2 - 10.1074/jbc.271.32.19503
DO - 10.1074/jbc.271.32.19503
M3 - Article
C2 - 8702641
AN - SCOPUS:0029666478
SN - 0021-9258
VL - 271
SP - 19503
EP - 19508
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 32
ER -